REGULATIONS
  • Rulings
  • AD/CVD
  • Notices
  • HTSUS
  • U.S. Code
  • Regs
  • More
    • Ports
    • About
    • Updates
    • Apps
    • Larger font
    • Smaller font
Regulations last checked for updates: May 15, 2025

Title 21 - Food and Drugs last revised: May 12, 2025
All TitlesTitle 21Chapter IPart 312Subpart E - Subpart E—Drugs Intended to Treat Life-threatening and Severely-debilitating Illnesses
  • § 312.80 - Purpose.
  • § 312.81 - Scope.
  • § 312.82 - Early consultation.
  • § 312.83 - Treatment protocols.
  • § 312.84 - Risk-benefit analysis in review of marketing applications for drugs to treat life-threatening and severely-debilitating illnesses.
  • § 312.85 - Phase 4 studies.
  • § 312.86 - Focused FDA regulatory research.
  • § 312.87 - Active monitoring of conduct and evaluation of clinical trials.
  • § 312.88 - Safeguards for patient safety.
source: 52 FR 8831, Mar. 19, 1987, unless otherwise noted.
.list_box li,p,.cm-search-info,.cm-search-detail,.abt span,.expand-collapse_top
© 2014 CustomsMobile | Disclaimer | Privacy | About
Get the CustomsMobile app!